Literature DB >> 24062870

A Global Review of Melanoma Follow-up Guidelines.

Shannon C Trotter1, Novie Sroa, Richard R Winkelmann, Thomas Olencki, Mark Bechtel.   

Abstract

Early detection of a melanoma recurrence is a major concern for the clinician. However, the follow-up care of melanoma patients lacks a uniform approach. Different dermatological and oncological organizations have developed their own strategies of follow-up management that vary by specialty and methods of screening for recurrence. Some areas of controversy in the follow-up care of melanoma patients include providers of care, use of staging versus Breslow depth to determine follow-up, the role of imaging and laboratory tests, frequency and duration of physical exams, and psychological well-being. Studies have evaluated these aspects of follow-up management, but no consensus exists. However, it is essential for clinicians to collaborate between specialties for an effective, evidence-based approach to melanoma clinical follow-up care.

Entities:  

Year:  2013        PMID: 24062870      PMCID: PMC3780800     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  27 in total

1.  Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians.

Authors:  N Provost; A A Marghoob; A W Kopf; M DeDavid; Q Wasti; R S Bart
Journal:  J Am Acad Dermatol       Date:  1997-05       Impact factor: 11.527

Review 2.  Follow-up in patients with localised primary cutaneous melanoma.

Authors:  Anne Brecht Francken; Esther Bastiaannet; Harald J Hoekstra
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

3.  Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.

Authors:  Yan Xing; Yulia Bronstein; Merrick I Ross; Robert L Askew; Jeffrey E Lee; Jeffrey E Gershenwald; Richard Royal; Janice N Cormier
Journal:  J Natl Cancer Inst       Date:  2010-11-16       Impact factor: 13.506

4.  Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas.

Authors:  M Weiss; C L Loprinzi; E T Creagan; R J Dalton; P Novotny; J R O'Fallon
Journal:  JAMA       Date:  1995-12-06       Impact factor: 56.272

5.  Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival.

Authors:  Hensin Tsao; Myra Feldman; Julie E Fullerton; Arthur J Sober; Daniel Rosenthal; William Goggins
Journal:  Arch Dermatol       Date:  2004-01

6.  A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.

Authors:  D B McKenna; J C Marioni; R J Lee; R J Prescott; V R Doherty
Journal:  Br J Dermatol       Date:  2004-09       Impact factor: 9.302

7.  Cost-effectiveness of reduced follow-up in malignant melanoma.

Authors:  Ulrich R Hengge; Andrea Wallerand; Andreas Stutzki; Norbert Kockel
Journal:  J Dtsch Dermatol Ges       Date:  2007-10       Impact factor: 5.584

Review 8.  Epidemiology of malignant melanoma.

Authors:  Renee A Desmond; Seng-jaw Soong
Journal:  Surg Clin North Am       Date:  2003-02       Impact factor: 2.741

9.  Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.

Authors:  Claus Garbe; Ulrike Leiter; Ulf Ellwanger; Hans-Juergen Blaheta; Friedegund Meier; Gernot Rassner; Birgit Schittek
Journal:  Cancer       Date:  2003-04-01       Impact factor: 6.860

10.  Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survival.

Authors:  U Hofmann; M Szedlak; W Rittgen; E G Jung; D Schadendorf
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

View more
  50 in total

1.  The value of FDG PET/CT for follow-up of patients with melanoma: a retrospective analysis.

Authors:  Philip H Vensby; Grethe Schmidt; Andreas Kjær; Barbara M Fischer
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-12-20

2.  Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor.

Authors:  Lena A von Schuckmann; Maria Celia B Hughes; Reza Ghiasvand; Maryrose Malt; Jolieke C van der Pols; Vanessa L Beesley; Kiarash Khosrotehrani; B Mark Smithers; Adele C Green
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

3.  Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.

Authors:  David E Elder; Michael W Piepkorn; Raymond L Barnhill; Gary M Longton; Heidi D Nelson; Stevan R Knezevich; Margaret S Pepe; Patricia A Carney; Linda J Titus; Tracy Onega; Anna N A Tosteson; Martin A Weinstock; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2018-03-07       Impact factor: 11.527

4.  Urethral involvement is associated with higher mortality and local recurrence in vulvar melanoma: a single institutional experience.

Authors:  Mitul B Modi; Phyllis A Gimotty; Michael E Ming; Neha Jariwala; Rosalie Elenitsas; Chris Miller; Emily Y Chu; Hanna Lindner; Ata S Moshiri; Lauren E Schwartz; Priti Lal; Maria C Reyes; David E Elder; Xiaowei Xu
Journal:  Hum Pathol       Date:  2020-07-20       Impact factor: 3.466

5.  Synergistic Anti-cancer Activity of MH-30 in a Murine Melanoma Model Treated With Cisplatin and its Alleviated Effects Against Cisplatin-induced Toxicity in Mice.

Authors:  Hae-Ran Park; Sung-Kee Jo; Hyang-Hee Cho; Uhee Jung
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

6.  Communication about melanoma and risk reduction after melanoma diagnosis.

Authors:  Vivian M Rodríguez; Marianne Berwick; Jennifer L Hay
Journal:  Psychooncology       Date:  2016-12-06       Impact factor: 3.894

7.  A Retrospective Analysis of Surveillance Adherence of Patients after Treatment of Primary Cutaneous Melanoma.

Authors:  Jeave Reserva; Monica Janeczek; Cara Joyce; Amanda Goslawski; Hwala Hong; Feng-Ning Yuan; Neelam Balasubramanian; Laura Winterfield; James Swan; Rebecca Tung
Journal:  J Clin Aesthet Dermatol       Date:  2017-12-01

8.  Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.

Authors:  A W L Bayci; D A Baker; A E Somerset; O Turkoglu; Z Hothem; R E Callahan; R Mandal; B Han; T Bjorndahl; D Wishart; R Bahado-Singh; S F Graham; R Keidan
Journal:  Metabolomics       Date:  2018-08-03       Impact factor: 4.290

Review 9.  Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.

Authors:  Amy A Mrazek; Celia Chao
Journal:  Surg Clin North Am       Date:  2014-08-05       Impact factor: 2.741

10.  MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1α.

Authors:  Yao Chen; K E Cao; Shaohua Wang; Jia Chen; Bin He; G U He; Yong Chen; Bin Peng; Jianda Zhou
Journal:  Exp Ther Med       Date:  2016-04-04       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.